Pay in 4 interest-free payments of $6.43 Learn more
Ships within 48 hours · Estimated delivery Sep 8 - Sep 13
Mochi providers help members explore GLP-1 and other clinically backed treatments with personalized plans designed for sustainable weight loss and long-term support
Massachusetts data reveal that specialty drugs have dominated spending growth for years: The Massachusetts Health Policy Commission (HPC) found that for commercially insured members, prescription drug spending (net of rebates) grew over 7% per year recently 10 faster than in previous years
Afshar uses multiple clinical measurements including InBody scans, routine bloodwork, liver and kidney ultrasounds, and blood pressure readings to assess whether GLP-1s could be prescribed to improve a patient's health
In fact, it is not fully understood why it works so well for many people, while others may not have any noticeable effects
Distribution of results: 86% lost at least 5% of body weight 69% lost at least 10% 50% lost at least 15% 32% lost at least 20% Subgroup analyses examining men specifically show similar percentage weight loss to women, though absolute pounds lost may be higher due to greater starting weights
US$ 27.40
US$ 24.78
US$ 20.02
